aspsirna0656 details

Purple = Wild vs mutant target sequence along with mutation information
Brown= Wild vs ASP-siRNA description along with positional differnece between two
Light pink= ASP siRNA efficacy for mutant vs wild allele
Green= Wild siRNA efficacy for Wild vs Mutant allele
siRNA Id:aspsirna0656
siRNA Name: ShAtx-3
Gene:Ataxin-3 (ATXN3)
Disease:Machado-Joseph Disease (MJD)/Spinocerebellar ataxia type 3 (SCA3)
Wild allele/target (5'->3'): GAUAGGUCCCCCUGCUGCU
Mutant allele/target (5'->3'):GAUAGGUCCCGCUGCUGCU
Target Mutation: c.892_894CAG(8_36),(p.Gln298_Gln305=)
Wild siRNA (As strand):CUAUCCAGGGGGACGACGA
ASP-siRNA (As strand):CUAUCCAGGGCGACGACGA
Mismatch position in siRNA: C9G
Mutant allele (5'->3'): GAUAGGUCCCGCUGCUGCU
ASP-siRNA (As strand):CUAUCCAGGGCGACGACGA
ASP-siRNA efficacy for mutant allele:25
Wild allele (5'->3'): GAUAGGUCCCCCUGCUGCU
ASP-siRNA (As strand):CUAUCCAGGGCGACGACGA
ASP-siRNA efficacy for wild allele:50
Percentage discrimination for ASP-siRNA:-25
Wild allele (5'->3'): GAUAGGUCCCCCUGCUGCU
Wild siRNA (As strand):CUAUCCAGGGGGACGACGA
Wild sirna efficacy for wild allele:NA
Wild allele (5'->3'): GAUAGGUCCCCCUGCUGCU
ASP-siRNA (As strand):CUAUCCAGGGCGACGACGA
Wild sirna efficacy for mutant allele:NA
Percentage discrimination for wild siRNA:NA
Concentration:6microM
Orientation:Sense
Mismatch in:siRNA
UniProt ID: P54252
Target sequence: CAGCAAAAGCAGCAACAGCAGCAGCAGCAGCAGCA
Genbank Accesion: NM_004993.5
Cell-line: Cerebellum of C57/BL6 mice
Experimental technique used: Western blot
Transfection method: Lipofectamine 2,000
siRNA expression method: Invitrogen
Post-transfection duration: 10 weeks post injection period
OMID ID: 109150
KEGG disease ID:H00063
Reference:23349684

.
.
.
.
.
.
.
.
.
.
.

.

.

.